KV Pharmaceutical Co. saw its profit fall sharply during the fourth quarter in part because of $5.1 million writeoff of certain research and development costs. The Brentwood company also said its holdings of auction rate securities are "illiquid" due to
Graphic designer Kelly Jay likens her website, GraphicLeftovers.com, to a garage sale for digital graphics. After all, it has the same mentality as a curbside sale: One person's unused artwork could be another person's treasure. It was Jay's own unused
Solutia Inc. Chief Executive Jeffry Quinn on Monday signed $182 million in contracts with companies from China, a country that looms large in his corporation's future as well as in the minds of many American executives. Quinn was in a
Anheuser-Busch Cos. reiterated Monday that its board of directors is studying a takeover bid by InBev, but the St. Louis-based brewer gave no indication of when the board might reach a decision. On Wednesday, Belgian brewer InBev made a nonbinding
As part of an ongoing restructuring, SSM HealthCare-St. Louis on Monday dismissed 75 members of its management team, including all hospital chief operating officers and vice presidents. Another 25 employees in human resources, finance and other administrative functions were let
Anheuser-Busch Cos. reiterated Monday that its board of directors is studying a takeover bid by InBev, but the St. Louis-based brewer gave no indication of when the board might reach a decision. On Wednesday, Belgian brewer InBev made a nonbinding
KV Pharmaceutical Co., based in Brentwood, saw its profit fall sharply during the fourth quarter in part because of $5.1 million write-off of certain research and development costs. The company also said its holdings of auction-rate securities are "illiquid" due
